Bio-Rad Laboratories reported $6.82B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Agilent USD 41.49B 8.93B Sep/2025
Becton, Dickinson and Co. USD 53.65B 4.28B Sep/2025
Bio Techne USD 8.66B 595M Sep/2025
Bio-Rad Laboratories USD 7.61B 1.08B Sep/2025
Bruker USD 4.93B 1.31B Sep/2025
Charles River Laboratories USD 7.31B 57M Sep/2025
Danaher USD 161.7B 29.34B Dec/2025
Exact Sciences USD 10.36B 334M Sep/2025
General Electric Aerospace USD 324.91B 5.91B Dec/2025
Hologic USD 16.62B 1.67B Dec/2025
Illumina USD 14.09B 1.01B Sep/2025
IQVIA Holdings USD 32.29B 5.03B Sep/2025
Laboratory Of America USD 23.83B 1.85B Sep/2025
Merck USD 293.38B 83.74B Feb/2026
Mettler Toledo International USD 25.29B 878M Sep/2025
Myriad Genetics USD 494M 316M Jun/2025
Quest Diagnostics USD 21.31B 1.26B Sep/2025
Repligen USD 7.52B 532M Sep/2025
Revvity USD 13.23B 3.47B Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Siemens EUR 183.36B 9.24B Sep/2025
Standard Biotools USD 521M 24M Feb/2026
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
Tosoh JPY 711.76B 25.84B Sep/2025
Waters USD 17.36B 3.61B Sep/2025